Literature DB >> 2901694

Cyclic GMP and cell death in rat cerebellar slices.

G Garthwaite1, J Garthwaite.   

Abstract

Incubated slices of young rat cerebellum were used to examine the possible relationship between the neurotoxic effects of excitatory amino acids and their ability to elicit large increases in the levels of cyclic GMP in this tissue. No cell death was detectable following exposure of the slices to the guanylate cyclase activator, nitroprusside (up to 0.3 mM), the phosphodiesterase inhibitor, isobutylmethylxanthine (0.5 mM), or to cyclic GMP (10 mM) and its dibutyryl and 8-bromo derivatives (0.5 mM). However, incubation of the slices with tbe guanylate cyclase inhibitors, N-methylhydroxylamine and hydroxylamine (0.1-1 mM), methylene blue (10-100 microM), ethacrynic acid (300 microM) and retinol (1 mM) caused a progressive destruction of the differentiating cells. The damage induced by N-methylhydroxylamine and hydroxylamine was inhibited by nitroprusside, cyclic GMP and isobutylmethylxanthine. It could also be reduced by lowering the partial pressure of oxygen, by oxygen radical scavenging enzymes and by omitting Ca2+ from the medium. Oxygen radical generating enzyme systems mimicked the pattern of toxicity of the guanylate cyclase inhibitors but their effects were not reduced by nitroprusside or omission of Ca2+. The results indicate that guanylate cyclase/cyclic GMP does not mediate amino acid neurotoxicity but, instead, may be part of a protective mechanism against oxygen free radicals.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2901694     DOI: 10.1016/0306-4522(88)90148-0

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  15 in total

1.  Protection by nicorandil against the dysfunction of the central vagal baroreflex system following transient global cerebral ischaemia in dogs.

Authors:  J Kurihara; N Ochiai; H Kato
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

Review 2.  Pharmacological and functional characterization of excitatory amino acid mediated cytotoxicity in cerebral cortical neurons.

Authors:  A Schousboe; A Frandsen; P Krogsgaard-Larsen
Journal:  Cell Biol Toxicol       Date:  1992 Jul-Sep       Impact factor: 6.691

Review 3.  Cellular and molecular actions of Methylene Blue in the nervous system.

Authors:  Murat Oz; Dietrich E Lorke; Mohammed Hasan; George A Petroianu
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

4.  Nitric oxide synthase inhibition prevents acute quinolinate-induced striatal neurotoxicity.

Authors:  F Pérez-Severiano; B Escalante; C Ríos
Journal:  Neurochem Res       Date:  1998-10       Impact factor: 3.996

5.  Xanthine dehydrogenase/xanthine oxidase and oxidative stress.

Authors:  H Y Chung; B S Baek; S H Song; M S Kim; J I Huh; K H Shim; K W Kim; K H Lee
Journal:  Age (Omaha)       Date:  1997-07

6.  Possible role of cGMP in excitatory amino acid induced cytotoxicity in cultured cerebral cortical neurons.

Authors:  A Frandsen; C F Andersen; A Schousboe
Journal:  Neurochem Res       Date:  1992-01       Impact factor: 3.996

7.  Cyclic GMP alterations in fetal rat cerebrum after global intrauterine ischemia: role of guanylate cyclase phosphorylation.

Authors:  E Magal; J Zwiller; M O Revel; E Yavin; J C Louis
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

8.  Role of nitric oxide and cyclic GMP in glutamate-induced neuronal death.

Authors:  C Montoliu; M Llansola; P Monfort; R Corbalan; I Fernandez-Marticorena; M L Hernandez-Viadel; V Felipo
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

9.  Domoic acid inhibits adenylate cyclase activity in rat brain membranes.

Authors:  M S Nijjar; B Grimmelt
Journal:  Mol Cell Biochem       Date:  1994-07-27       Impact factor: 3.396

10.  Effect of L-arginine/nitric oxide pathway on MPP(+)-induced cell injury in the striatum of rats.

Authors:  M Santiago; A Machado; J Cano
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.